Ó£»¨ÊÓƵ

Skip to main content
Fig. 4 | Ó£»¨ÊÓƵ

Fig. 4

From: The progress of mother-to-child transmission of Human Immunodeficiency Virus (HIV) after Dolutegravir (DTG) optimization program: evidence from a multicenter cohort study in Ethiopia

Fig. 4

Cumulative incidence of MTCT with 95% among HIV-exposed infants by maternal ART duration. Figure 4a–c shows the cumulative incidence of MTCT among HIV-exposed infants by maternal ART duration during PMTCT Care (2017–2022 Birth Cohorts) in selected hospitals in Ethiopia ; 4a) Perinatal MTCT ( N = 2521), 4b) Breastfeeding MTCT ( N = 2281), and 4c) end of care MTCT (2311)

Back to article page